共 50 条
- [23] COMBINED EFFECT SIZE - COMMENT ON THE METAANALYSIS OF 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1991, 34 (10): : 1342 - 1342
- [24] THE COMPARATIVE EFFICACY AND TOXICITY OF 2ND-LINE DRUGS IN RHEUMATOID-ARTHRITIS - RESULTS OF 2 METAANALYSES ARTHRITIS AND RHEUMATISM, 1990, 33 (10): : 1449 - 1461
- [25] SECULAR CHANGES IN PUBLISHED CLINICAL-TRIALS OF 2ND-LINE AGENTS IN RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1991, 34 (10): : 1304 - 1309
- [27] DOES PREVIOUS 2ND-LINE THERAPY INFLUENCE THE CLINICAL-RESPONSE TO SULFASALAZINE IN RHEUMATOID-ARTHRITIS BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 (01): : 113 - 113
- [28] PHENYTOIN IS LESS EFFECTIVE THAN GOLD AS A 2ND LINE AGENT IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA) BRITISH JOURNAL OF RHEUMATOLOGY, 1987, 26 : 9 - 10
- [29] RISK-FACTORS FOR THE DISCONTINUATION OF 2ND-LINE ANTIRHEUMATIC DRUGS IN RHEUMATOID-ARTHRITIS - A PROSPECTIVE ANALYSIS BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 207 - 207